This RCSEd webinar examines cell-based and gene therapies for musculoskeletal injuries and degenerative conditions, connecting biological mechanisms with clinical evidence and the challenges of translating research into treatment.
What the session covers
Stem-cell sources and gene-delivery strategies, including their mechanisms, advantages and limitations.
Clinical applications and evidence in trauma, cartilage repair, bone regeneration and degenerative musculoskeletal disease.
Safety, regulation, scalability, standardisation and clinical trial design.
Audience: Orthopaedic professionals interested in the science and clinical translation of emerging biological therapies.
Session details
When: 23 November 2026, 19:00 to 20:00 GMT.
Format: Live online webinar.
Panellists: Professor Martin J. Stoddart, Vice-Director and Programme Leader for Regenerative Orthopaedics, and Dr Elena Della Bella, Senior Scientist and Deputy Focus Area Leader in Progenitor Cell Biology, both at the AO Research Institute Davos.
Organiser: The Royal College of Surgeons of Edinburgh Trauma and Orthopaedic Surgical Specialty Board.
Registration, CPD and recording
Register through the form on the RCSEd event page. One CPD hour is available for attending the full live webinar and completing the feedback survey. The survey must be completed within seven days, using the same email address as the webinar registration.
A recording is planned for the event page after the broadcast. Archived recordings in this series are a benefit for RCSEd Fellows, Members and Affiliates. Watching a recording does not qualify for a CPD certificate.